Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 9803851, 9 pages
https://doi.org/10.1155/2018/9803851
Research Article

Association between Low Free Triiodothyronine Levels and Poor Prognosis in Patients with Acute ST-Elevation Myocardial Infarction

1Department of Cardiology, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China
2PLA Institute of Cardiovascular Disease, Chongqing 400037, China

Correspondence should be addressed to Lan Huang; nc.ude.ummt@gnauhl

Received 2 November 2017; Revised 16 January 2018; Accepted 23 January 2018; Published 16 April 2018

Academic Editor: Ramazan Akdemir

Copyright © 2018 Yuanbin Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Fliers, A. C. Bianco, L. Langouche, and A. Boelen, “Thyroid function in critically ill patients,” The Lancet Diabetes & Endocrinology, vol. 3, no. 10, pp. 816–825, 2015. View at Publisher · View at Google Scholar
  2. A. Jabbar, A. Pingitore, S. H. S. Pearce, A. Zaman, G. Iervasi, and S. Razvi, “Thyroid hormones and cardiovascular disease,” Nature Reviews Cardiology, vol. 14, no. 1, pp. 39–55, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Olivares, M. P. Marassi, R. S. Fortunato et al., “Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats—a time course study,” Endocrinology, vol. 148, no. 10, pp. 4786–4792, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. J. Pol, A. Muller, M. J. Zuidwijk et al., “Left-ventricular remodeling after myocardial infarction is associated with a cardiomyocyte-specific hypothyroid condition,” Endocrinology, vol. 152, no. 2, pp. 669–679, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Chen, B. Yan, F. Wang et al., “Type 1 5'-deiodinase activity is inhibited by oxidative stress and restored by alpha-lipoic acid in HepG2 cells,” Biochemical and Biophysical Research Communications, vol. 472, no. 3, pp. 496–501, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Boelen, J. Kwakkel, and E. Fliers, “Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection,” Endocrine Reviews, vol. 32, no. 5, pp. 670–693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. C. J. Pol, A. Muller, and W. S. Simonides, “Cardiomyocyte-specific inactivation of thyroid hormoneb in pathologic ventricular hypertrophy: An adaptative response or part of the problem,” Heart Failure Reviews, vol. 15, no. 2, pp. 133–142, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Klein and K. Ojamaa, “Thyroid hormone and the cardiovascular system,” The New England Journal of Medicine, vol. 344, no. 7, pp. 501–509, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. F. J. Giordano, “Oxygen, oxidative stress, hypoxia, and heart failure,” The Journal of Clinical Investigation, vol. 115, no. 5, pp. 500–508, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Mei, M. D. Thompson, R. A. Cohen, and X. Tong, “Autophagy and oxidative stress in cardiovascular diseases,” Biochimica et Biophysica Acta, vol. 1852, no. 2, pp. 243–251, 2015. View at Publisher · View at Google Scholar
  11. I. Mourouzis, P. Mantzouratou, G. Galanopoulos et al., “Dose-dependent effects of thyroid hormone on post-ischemic cardiac performance: Potential involvement of Akt and ERK signalings,” Molecular and Cellular Biochemistry, vol. 363, no. 1-2, pp. 235–243, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. A. Hamilton, L. W. Stevenson, M. Luu, and J. A. Walden, “Altered thyroid hormone metabolism in advanced heart failure,” Journal of the American College of Cardiology, vol. 16, no. 1, pp. 91–95, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. K. S. Özcan, D. Osmonov, E. Toprak et al., “Sick euthyroid syndrome is associated with poor prognosis in patients with ST segment elevation myocardial infarction undergoing primary percutaneous intervention,” Cardiology Journal, vol. 21, no. 3, pp. 238–244, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Zhang, W. Peng, C. Wang, W. Li, and Y. Xu, “A low fT3 level as a prognostic marker in patients with acute myocardial infarctions,” Internal Medicine, vol. 51, no. 21, pp. 3009–3015, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. G. D. Rothberger, S. Gadhvi, N. Michelakis, A. Kumar, R. Calixte, and L. E. Shapiro, “Usefulness of Serum Triiodothyronine (T3) to Predict Outcomes in Patients Hospitalized With Acute Heart Failure,” American Journal of Cardiology, vol. 119, no. 4, pp. 599–603, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Okayama, Y. Minami, S. Kataoka, T. Shiga, and N. Hagiwara, “Thyroid function on admission and outcome in patients hospitalized for acute decompensated heart failure,” Journal of Cardiology, vol. 66, no. 3, pp. 205–211, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Kozdag, G. Ertas, T. Kilic, E. Acar, T. Sahin, and D. Ural, “Triiodothyronine and brain natriuretic peptide: Similar long-term prognostic values for chronic heart failure,” Texas Heart Institute Journal, vol. 37, no. 5, pp. 538–546, 2010. View at Google Scholar · View at Scopus
  18. J. E. Mitchell, A. S. Hellkamp, D. B. Mark et al., “Thyroid function in heart failure and impact on mortality,” JACC: Heart Failure, vol. 1, no. 1, pp. 48–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Y. Wang, Y. D. Tang, M. Yang et al., “Free triiodothyronine level indicates the degree of myocardial injury in patients with acute ST-elevation myocardial infarction,” Chinese Medical Journal, vol. 126, pp. 3926–3929, 2013. View at Google Scholar
  20. A. Frey, M. Kroiss, D. Berliner et al., “Prognostic impact of subclinical thyroid dysfunction in heart failure,” International Journal of Cardiology, vol. 168, no. 1, pp. 300–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. A. C. Perez, P. S. Jhund, D. J. Stott et al., “Thyroid-Stimulating Hormone and Clinical Outcomes: The CORONA Trial (Controlled Rosuvastatin Multinational Study in Heart Failure),” JACC: Heart Failure, vol. 2, no. 1, pp. 35–40, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Friberg, V. Drvota, A. H. Bjelak, G. Eggertsen, and S. Ahnve, “Association between increased levels of reverse triiodothyronine and mortality after acute myocardial infarction,” American Journal of Medicine, vol. 111, no. 9, pp. 699–703, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Lamprou, D. Varvarousis, K. Polytarchou, G. Varvarousi, and T. Xanthos, “The role of thyroid hormones in acute coronary syndromes: Prognostic value of alterations in thyroid hormones,” Clinical Cardiology, vol. 40, no. 8, pp. 528–533, 2017. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Stoppa-Vaucher, G. Van Vliet, and J. Deladoëy, “Variation by ethnicity in the prevalence of congenital hypothyroidism due to thyroid dysgenesis,” Thyroid, vol. 21, no. 1, pp. 13–18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. I. M. Korevaar, M. Medici, Y. B. De Rijke et al., “Ethnic differences in maternal thyroid parameters during pregnancy: The generation r study,” The Journal of Clinical Endocrinology & Metabolism, vol. 98, no. 9, pp. 3678–3686, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. A. McLeod, P. Caturegli, D. S. Cooper, P. G. Matos, and S. Hutfless, “Variation in rates of autoimmune thyroid disease by race/ethnicity in US military personnel,” Journal of the American Medical Association, vol. 311, no. 15, pp. 1563–1565, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. F. G. Kushner, M. Hand, S. C. Smith Jr. et al., “2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation, vol. 120, pp. 2271–2306, 2009. View at Google Scholar
  28. G. Iervasi, A. Pingitore, P. Landi et al., “Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease,” Circulation, vol. 107, no. 5, pp. 708–713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Wang, S. Liu, L. Li et al., “Non-thyroidal illness syndrome in patients with cardiovascular diseases: A systematic review and meta-analysis,” International Journal of Cardiology, vol. 226, pp. 1–10, 2017. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Lazzeri, A. Sori, C. Picariello, M. Chiostri, G. F. Gensini, and S. Valente, “Nonthyroidal illness syndrome in ST-elevation myocardial infarction treated with mechanical revascularization,” International Journal of Cardiology, vol. 158, no. 1, pp. 103-104, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Lymvaios, I. Mourouzis, D. V. Cokkinos, M. A. Dimopoulos, S. T. Toumanidis, and C. Pantos, “Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction: A strong association?” European Journal of Endocrinology, vol. 165, no. 1, pp. 107–114, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Li, X. Li, Q. Wang et al., “ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data,” The Lancet, vol. 385, no. 9966, pp. 441–451, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. S. D. Kristensen, K. G. Laut, J. Fajadet et al., “Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: Current status in 37 ESC countries,” European Heart Journal, vol. 35, no. 29, pp. 1957–1970, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Widimsky, W. Wijns, J. Fajadet et al., “Reperfusion therapy for ST elevation acute myocardial infarction in Europe: Description of the current situation in 30 countries,” European Heart Journal, vol. 31, no. 8, pp. 943–957, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. H. N. Pavlou, P. A. Kliridis, A. A. Panagiotopoulos, C. P. Goritsas, and P. J. Vassilakos, “Euthyroid sick syndrome in acute ischemic syndromes,” Angiology, vol. 53, no. 6, pp. 699–707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Van Den Berghe, F. De Zegher, R. C. Baxter et al., “Neuroendocrinology of prolonged critical illness: Effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues,” The Journal of Clinical Endocrinology & Metabolism, vol. 83, no. 2, pp. 309–319, 1998. View at Publisher · View at Google Scholar · View at Scopus
  37. M. H. Warner and G. J. Beckett, “Mechanisms behind the non-thyroidal illness syndrome: An update,” Journal of Endocrinology, vol. 205, no. 1, pp. 1–13, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Boelen, M. C. Platvoet-Ter Schiphorst, and W. M. Wiersinga, “Association between serum interleukin-6 and serum 3,5,3-triiodothyronine in nonthyroidal illness,” The Journal of Clinical Endocrinology & Metabolism, vol. 77, no. 6, pp. 1695–1699, 1993. View at Publisher · View at Google Scholar · View at Scopus
  39. T. van der Poll, J. A. Romijn, W. M. Wiersinga, and H. P. Sauerwein, “Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man,” The Journal of Clinical Endocrinology & Metabolism, vol. 71, no. 6, pp. 1567–1572, 1990. View at Publisher · View at Google Scholar · View at Scopus
  40. E. P. M. Corssmit, R. Heyligenberg, E. Endert, H. P. Sauerwein, and J. A. Romijn, “Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men,” The Journal of Clinical Endocrinology & Metabolism, vol. 80, no. 11, pp. 3140–3144, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. A. L. De Castro, R. O. Fernandes, V. D. Ortiz et al., “Thyroid hormones improve cardiac function and decrease expression of pro-apoptotic proteins in the heart of rats 14 days after infarction,” Apoptosis, vol. 21, no. 2, pp. 184–194, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. A. L. De Castro, A. V. Tavares, C. Campos et al., “Cardioprotective effects of thyroid hormones in a rat model of myocardial infarction are associated with oxidative stress reduction,” Molecular and Cellular Endocrinology, vol. 391, no. 1-2, pp. 22–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  43. A. L. de Castro, A. V. Tavares, R. O. Fernandes et al., “T3 and T4 decrease ROS levels and increase endothelial nitric oxide synthase expression in the myocardium of infarcted rats,” Molecular and Cellular Biochemistry, vol. 408, no. 1-2, pp. 235–243, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. A. Pingitore, G. Nicolini, C. Kusmic, G. Iervasi, P. Grigolini, and F. Forini, “Cardioprotection and thyroid hormones,” Heart Failure Reviews, vol. 21, no. 4, pp. 391–399, 2016. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Pantos, I. Mourouzis, T. Saranteas et al., “Thyroid hormone improves postischaemic recovery of function while limiting apoptosis: A new therapeutic approach to support hemodynamics in the setting of ischaemia-reperfusion?” Basic Research in Cardiology, vol. 104, no. 1, pp. 69–77, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Pantos, I. Mourouzis, K. Markakis, N. Tsagoulis, M. Panagiotou, and D. V. Cokkinos, “Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats,” Basic Research in Cardiology, vol. 103, no. 4, pp. 308–318, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. I. Mourouzis, E. Kostakou, G. Galanopoulos, P. Mantzouratou, and C. Pantos, “Inhibition of thyroid hormone receptor α1 impairs post-ischemic cardiac performance after myocardial infarction in mice,” Molecular and Cellular Biochemistry, vol. 379, no. 1-2, pp. 97–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Pantos, I. Mourouzis, G. Galanopoulos et al., “Thyroid hormone receptor 1 downregulation in postischemic heart failure progression: The potential role of tissue hypothyroidism,” Hormone and Metabolic Research, vol. 42, no. 10, pp. 718–724, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Pantos and I. Mourouzis, “Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair,” Heart Failure Reviews, vol. 20, no. 3, pp. 273–282, 2015. View at Publisher · View at Google Scholar · View at Scopus